Risk of adverse events in patients prescribed long‐term opioids: A cohort study in the UK Clinical Practice Research Datalink

Long‐term opioid prescribing for musculoskeletal pain is controversial due to uncertainty regarding effectiveness and safety. This study examined the risks of a range of adverse events in a large cohort of patients prescribed long‐term opioids using the UK Clinical Practice Research Datalink.

[1]  Diana Gosálvez Prados.  KING'S Fund. , 1953, British medical journal.

[2]  A. Wilson.  The British National Formulary. , 1963, The Practitioner.

[3]  N. Booth.  What are the Read Codes? , 1994, Health libraries review.

[4]  D H Lawson,et al.  The General Practice Research Database. Scientific and Ethical Advisory Group. , 1998, QJM : monthly journal of the Association of Physicians.

[5]  H. Daniell.  Hypogonadism in men consuming sustained-action oral opioids. , 2002, The journal of pain : official journal of the American Pain Society.

[6]  D. Cucinotta,et al.  Musculoskeletal pain in Europe: its impact and a comparison of population and medical perceptions of treatment in eight European countries , 2004, Annals of the rheumatic diseases.

[7]  L. Wood,et al.  The General Practice Research Database , 2004, Drug safety.

[8]  John W. Williams,et al.  Common comorbidity scales were similar in their ability to predict health care costs and mortality. , 2004, Journal of clinical epidemiology.

[9]  K. Jordan,et al.  Characterizing the course of low back pain: a latent class analysis. , 2006, American journal of epidemiology.

[10]  B. Collett,et al.  Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment , 2006, European journal of pain.

[11]  S. Tripathi,et al.  Epidemiology of regular prescribed opioid use: results from a national, population-based survey. , 2008, Journal of pain and symptom management.

[12]  C. Rutter,et al.  De Facto Long-term Opioid Therapy for Noncancer Pain , 2008, The Clinical journal of pain.

[13]  N. Mazer,et al.  The Impact of Opioids on the Endocrine System , 2009, The Clinical journal of pain.

[14]  F. Chan,et al.  Guidelines for Prevention of NSAID-Related Ulcer Complications , 2009, The American Journal of Gastroenterology.

[15]  K. Jordan,et al.  Annual consultation prevalence of regional musculoskeletal problems in primary care: an observational study , 2010, BMC musculoskeletal disorders.

[16]  M. Lipsitch,et al.  Negative Controls: A Tool for Detecting Confounding and Bias in Observational Studies , 2010, Epidemiology.

[17]  J. Rassen,et al.  The comparative safety of opioids for nonmalignant pain in older adults. , 2011, Archives of internal medicine.

[18]  L. Smeeth,et al.  Validation and validity of diagnoses in the General Practice Research Database: a systematic review , 2010, British journal of clinical pharmacology.

[19]  L. Manchikanti,et al.  Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. , 2010, Pain physician.

[20]  B. Psaty,et al.  Opioid Prescriptions for Chronic Pain and Overdose , 2010, Annals of Internal Medicine.

[21]  B. Horisberger,et al.  The course of chronic and recurrent low back pain in the general population , 2010, Pain.

[22]  B. Psaty,et al.  Relationship of Opioid Use and Dosage Levels to Fractures in Older Chronic Pain Patients , 2010, Journal of general internal medicine.

[23]  M. Doherty,et al.  A randomised controlled trial of ibuprofen, paracetamol or a combination tablet of ibuprofen/paracetamol in community-derived people with knee pain , 2011, Annals of the rheumatic diseases.

[24]  A. O'dowd.  Some PCTs recommend GPs limit prescriptions to 28 days , 2011, BMJ : British Medical Journal.

[25]  T. V. van Staa,et al.  Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource , 2012, Therapeutic advances in drug safety.

[26]  C. Stannard.  Opioids in the UK: what’s the problem? , 2013, BMJ.

[27]  K. Freedland,et al.  Prescription Opioid Analgesics Increase the Risk of Depression , 2014, Journal of General Internal Medicine.

[28]  E. Kalso,et al.  Expect analgesic failure; pursue analgesic success , 2013, BMJ.

[29]  L-C Chen,et al.  Changes in trends and pattern of strong opioid prescribing in primary care , 2014, European journal of pain.

[30]  B. Martin,et al.  The Role of Opioid Prescription in Incident Opioid Abuse and Dependence Among Individuals With Chronic Noncancer Pain: The Role of Opioid Prescription , 2013, The Clinical journal of pain.

[31]  Natalia Beloff,et al.  Exploiting the potential of large databases of electronic health records for research using rapid search algorithms and an intuitive query interface , 2013, J. Am. Medical Informatics Assoc..

[32]  S. Burge,et al.  Change in opioid dose and change in depression in a longitudinal primary care patient cohort , 2015, Pain.

[33]  Communities.  English Indices of Deprivation 2010 , 2015 .

[34]  M. Crowell,et al.  Opioid-Induced Esophageal Dysfunction (OIED) in Patients on Chronic Opioids , 2015, The American Journal of Gastroenterology.

[35]  D. Bauer,et al.  Association of Opioids with Falls, Fractures, and Physical Performance among Older Men with Persistent Musculoskeletal Pain , 2016, Journal of General Internal Medicine.

[36]  R. Chou,et al.  The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop , 2015, Annals of Internal Medicine.

[37]  K. Bhaskaran,et al.  Data Resource Profile: Clinical Practice Research Datalink (CPRD) , 2015, International journal of epidemiology.

[38]  Innere Medizin.  Long-term opioid therapy in chronic noncancer pain A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks , 2015 .

[39]  Benjamin H. Leaman,et al.  Prescribed opioids in primary care: cross-sectional and longitudinal analyses of influence of patient and practice characteristics , 2016, BMJ Open.

[40]  B. Arnold,et al.  Brief Report: Negative Controls to Detect Selection Bias and Measurement Bias in Epidemiologic Studies , 2016, Epidemiology.

[41]  K. Bucholz,et al.  Prescription Opioid Duration, Dose, and Increased Risk of Depression in 3 Large Patient Populations , 2016, The Annals of Family Medicine.

[42]  M. Doherty,et al.  Paracetamol: not as safe as we thought? A systematic literature review of observational studies , 2015, Annals of the rheumatic diseases.

[43]  K. Murray,et al.  Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain. , 2016, JAMA.

[44]  K. Walters,et al.  Trends in long-term opioid prescribing in primary care patients with musculoskeletal conditions: an observational database study , 2016, Pain.

[45]  Amanuel Medhanie,et al.  Development and Applications of the Veterans Health Administration’s Stratification Tool for Opioid Risk Mitigation (STORM) to Improve Opioid Safety and Prevent Overdose and Suicide , 2017, Psychological services.

[46]  J. Pérez-Cajaraville,et al.  European Pain Federation position paper on appropriate opioid use in chronic pain management , 2016, European journal of pain.

[47]  I. Rutks,et al.  Design, recruitment outcomes, and sample characteristics of the Strategies for Prescribing Analgesics Comparative Effectiveness (SPACE) trial. , 2017, Contemporary clinical trials.

[48]  V. G. Lappi,et al.  Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews. , 2017, The Cochrane database of systematic reviews.

[49]  D. A. van der Windt,et al.  Generic prognostic factors for musculoskeletal pain in primary care: a systematic review , 2017, BMJ Open.

[50]  K. Dunn,et al.  Increased risk of reproductive dysfunction in women prescribed long‐term opioids for musculoskeletal pain: A matched cohort study in the Clinical Practice Research Datalink , 2018, European journal of pain.

[51]  N. Foster,et al.  Clinical course and prognostic factors across different musculoskeletal pain sites: A secondary analysis of individual patient data from randomised clinical trials , 2018, European journal of pain.